Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $528000.0.

  • Jaguar Health's Change in Accured Expenses rose 27087.38% to $528000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $913000.0, marking a year-over-year increase of 6970.26%. This contributed to the annual value of -$1.1 million for FY2024, which is 6172.59% up from last year.
  • Latest data reveals that Jaguar Health reported Change in Accured Expenses of $528000.0 as of Q3 2025, which was up 27087.38% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Change in Accured Expenses ranged from a high of $3.3 million in Q1 2022 and a low of -$6.7 million during Q3 2023
  • Its 5-year average for Change in Accured Expenses is $36684.2, with a median of $141000.0 in 2025.
  • Per our database at Business Quant, Jaguar Health's Change in Accured Expenses skyrocketed by 111727.75% in 2021 and then plummeted by 572400.0% in 2022.
  • Quarter analysis of 5 years shows Jaguar Health's Change in Accured Expenses stood at $1.0 million in 2021, then tumbled by 281.01% to -$1.9 million in 2022, then soared by 125.32% to $473000.0 in 2023, then tumbled by 352.85% to -$1.2 million in 2024, then surged by 144.15% to $528000.0 in 2025.
  • Its Change in Accured Expenses stands at $528000.0 for Q3 2025, versus $1.4 million for Q2 2025 and $141000.0 for Q1 2025.